Pharmena S.A. (WSE:PHR)
3.570
-0.060 (-1.65%)
Jan 28, 2026, 4:40 PM CET
Pharmena Revenue
Pharmena had revenue of 407.00K PLN in the quarter ending September 30, 2025, with 1,750.00% growth. This brings the company's revenue in the last twelve months to 1.27M, up 313.64% year-over-year. In the year 2024, Pharmena had annual revenue of 268.00K, down -10.37%.
Revenue (ttm)
1.27M
Revenue Growth
+313.64%
P/S Ratio
31.73
Revenue / Employee
182.00K
Employees
7
Market Cap
40.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 268.00K | -31.00K | -10.37% |
| Dec 31, 2023 | 299.00K | - | - |
| Dec 31, 2022 | 299.00K | -14.91M | -98.03% |
| Dec 31, 2021 | 15.21M | 5.28M | 53.16% |
| Dec 31, 2020 | 9.93M | -1.17M | -10.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 295.81M |
| Ryvu Therapeutics | 90.41M |
| Synthaverse | 71.76M |
| Mabion | 14.81M |
| Captor Therapeutics Spolka Akcyjna | 7.57M |
| Molecure | 5.86M |
| Urteste | 1.80M |
| Poltreg | 250.00K |